[{"address1": "200 Granville Street", "address2": "Suite 2820", "city": "Vancouver", "state": "BC", "zip": "V6C 1S4", "country": "Canada", "phone": "604 336 7906", "website": "https://www.aequuspharma.ca", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Douglas Glen Janzen", "age": 55, "title": "Chairman, CEO & President", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0012, "open": 0.0012, "dayLow": 0.0012, "dayHigh": 0.0012, "regularMarketPreviousClose": 0.0012, "regularMarketOpen": 0.0012, "regularMarketDayLow": 0.0012, "regularMarketDayHigh": 0.0012, "payoutRatio": 0.0, "beta": -0.238, "volume": 475, "regularMarketVolume": 475, "averageVolume": 10761, "averageVolume10days": 23786, "averageDailyVolume10Day": 23786, "bid": 0.0012, "ask": 0.004, "bidSize": 529240, "askSize": 179985, "marketCap": 487426, "fiftyTwoWeekLow": 0.0001, "fiftyTwoWeekHigh": 0.00783, "allTimeHigh": 0.5675, "allTimeLow": 0.0001, "priceToSalesTrailing12Months": 0.59804374, "fiftyDayAverage": 0.00245, "twoHundredDayAverage": 0.00346525, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6946833, "profitMargins": -2.01409, "floatShares": 113163697, "sharesOutstanding": 132634431, "heldPercentInsiders": 0.1468, "heldPercentInstitutions": 0.0, "impliedSharesOutstanding": 187471538, "bookValue": -0.055, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -1641551, "trailingEps": -0.01, "enterpriseToRevenue": 8.523, "52WeekChange": -0.63380283, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 0.0026, "recommendationKey": "none", "totalCash": 35079, "totalCashPerShare": 0.0, "totalDebt": 6637063, "quickRatio": 0.016, "currentRatio": 0.033, "totalRevenue": 815034, "revenuePerShare": 0.006, "returnOnAssets": -1.03813, "grossProfits": 466415, "freeCashflow": -115996, "operatingCashflow": -443317, "revenueGrowth": 0.352, "grossMargins": 0.57226, "ebitdaMargins": 0.0, "operatingMargins": -0.42071, "financialCurrency": "CAD", "symbol": "AQSZF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "corporateActions": [], "regularMarketTime": 1763154000, "exchange": "PNK", "messageBoardId": "finmb_247433914", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": 0.00014999998, "fiftyDayAverageChangePercent": 0.06122448, "twoHundredDayAverageChange": -0.0008652499, "twoHundredDayAverageChangePercent": -0.24969336, "priceToBook": -0.047272727, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "shortName": "Aequus Pharmaceuticals Inc.", "longName": "Aequus Pharmaceuticals Inc.", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1434461400000, "regularMarketChange": 0.0014, "regularMarketDayRange": "0.0012 - 0.0012", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 10761, "fiftyTwoWeekLowChange": 0.0025, "fiftyTwoWeekLowChangePercent": 25.0, "fiftyTwoWeekRange": "1.0E-4 - 0.00783", "fiftyTwoWeekHighChange": -0.0052299993, "fiftyTwoWeekHighChangePercent": -0.6679438, "fiftyTwoWeekChangePercent": -63.380283, "earningsTimestampStart": 1763413200, "earningsTimestampEnd": 1763413200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.01, "marketState": "CLOSED", "regularMarketChangePercent": 116.666664, "regularMarketPrice": 0.0026, "displayName": "Aequus Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]